Proceedings of the National Academy of Sciences · 2020 · 47 citations · 45 references
Life SciencesGeneticsNeurologyAutoimmunityMolecular NeuroscienceNeuroimmunologyB Cell BiologyDemyelinating DisordersDisease Susceptibility LociMultiple SclerosisNeurodegenerative DiseasesNeurodegenerative DisordersAutoimmune DemyelinationDemyelination PathophysiologyExperimental Autoimmune EncephalomyelitisMultiple Sclerosis ImmunopathogenesisMultiple Sclerosis NeuroprotectionPolyglutamine DiseasesSpinocerebellar Ataxia GeneticsSpinocerebellar Ataxia Type 1
Significance Over 200 genomic loci have been found associated with the risk of developing multiple sclerosis (MS). Despite this important body of data, limited information exists on the cellular pathways and molecular mechanisms underlying MS genetic complexity. In this study, we report the functional characterization of the ataxin-1 encoding ATXN1 susceptibility locus. Ataxin-1 is a polyglutamine protein that is classically associated with the neurodegenerative disorder spinocerebellar ataxia type 1 (SCA1). Here, we show that ataxin-1 also exerts a protective activity against autoimmune demyelination in a preclinical model of MS. This function is associated with an immunomodulatory role mainly targeting the B cell compartment. Altogether, these findings expand our current knowledge on both MS pathogenesis and ataxin-1 biology.
45
A subcellular map of the human proteome
Peter Thul, Lovisa Åkesson, Mikaela Wiking et al. · Science · 2017 · 3K citations
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
Stephen L. Hauser, Amit Bar‐Or, Gavin Giovannoni et al. · New England Journal of Medicine · 2016 · 2K citations · Full text
Life Sciences, Immunology, Neurology +17
Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1
Harry T. Orr, Ming‐Yi Chung, Sandro Banfi et al. · Nature Genetics · 1993 · 1.7K citations